These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 6420923

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [Abstract] [Full Text] [Related]

  • 3. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD, Kinlough-Rathbone RL, Mustard JF.
    Thromb Haemost; 1981 Jun 30; 45(3):257-62. PubMed ID: 7281105
    [Abstract] [Full Text] [Related]

  • 4. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP.
    Basic Clin Pharmacol Toxicol; 2005 Sep 30; 97(3):162-7. PubMed ID: 16128910
    [Abstract] [Full Text] [Related]

  • 5. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid.
    Brammer JP, Maguire MH.
    Br J Pharmacol; 1984 May 30; 82(1):61-72. PubMed ID: 6428500
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets.
    Liao CH, Liao CH, Chang YL, Guh JH, Kuo SC, Huang LJ, Teng CM.
    J Pharm Pharmacol; 2002 Jul 30; 54(7):967-74. PubMed ID: 12162716
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P, Blockmans D, Deckmyn H, Vermylen J.
    J Pharmacol Exp Ther; 1988 Jul 30; 246(1):301-7. PubMed ID: 3134542
    [Abstract] [Full Text] [Related]

  • 14. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH, Csonka-Khalifah L.
    Biochim Biophys Acta; 1987 Oct 17; 921(3):426-36. PubMed ID: 3117116
    [Abstract] [Full Text] [Related]

  • 15. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ, Foster MR, McCabe PJ, Stratton LE.
    Thromb Haemost; 1989 Jun 30; 61(3):429-36. PubMed ID: 2529661
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin biosynthesis in rabbit kidney: mepacrine inhibits renomedullary cyclooxygenase.
    Erman A, Azuri R, Raz A.
    Biochem Pharmacol; 1984 Jan 01; 33(1):79-82. PubMed ID: 6422941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.